๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sublingual and oral isoxsuprine in patients with Raynaud's phenomenon

โœ Scribed by H. Wesseling; A. Heeten; A. A. Wouda

Publisher
Springer
Year
1981
Tongue
English
Weight
524 KB
Volume
20
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Once daily felodipine in patients with p
Once daily felodipine in patients with primary Raynaud's phenomenon
โœ C. G. M. Kallenberg; A. A. Wouda; L. Meems; H. Wesseling ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› Springer ๐ŸŒ English โš– 289 KB

The symptomatic effects of felodipine (Plendil) have been assessed in 10 patients with primary Raynaud's phenomenon in a single blind study. After 2 weeks on placebo, the patients were treated for 6 weeks with felodipine, the dose being titrated stepwise every 2 weeks, starting with 5 mg, and increa

Measuring disease activity and functiona
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
โœ Peter A. Merkel; Karen Herlyn; Richard W. Martin; Jennifer J. Anderson; Maureen ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 95 KB ๐Ÿ‘ 2 views

## Abstract ## Objective To document disease activity and functional status in patients with scleroderma (systemic sclerosis [SSc]) and Raynaud's phenomenon (RP) and to determine the sensitivity to change, reliability, ease of use, and validity of various outcome measures in these patients. ## Me